ACTIVITY OVERVIEW | This Webcast contains video and downloadable slides from the symposium Glioblastoma: Expert Perspectives on Current Standards of Care and Novel Approaches, a prIME Oncology educational activity that was held on November 18, 2011 in Orange County, California. |
FACULTY | Chair
Michael Prados, MD
University of California, San Francisco
San Francisco, California, United States
Faculty
Timothy Cloughesy, MD
University of California, Los Angeles
Los Angeles, California, United States
Minesh P. Mehta, MD
Northwestern University
Feinberg School of Medicine
Chicago, Illinois, United States
Wolfgang Wick, MD, PhD
University of Heidelberg and German Cancer Research Center
Heidelberg, Germany |
TARGET AUDIENCE | This educational activity is intended specifically for medical oncologists, neurologists, surgeons, and other healthcare professionals involved and/or interested in the management of patients with glioblastoma.
|
|
|
 |
|
Expert Discussion
|
 |
|
Downloadable Slides
|
|
 |
TOPICS | Applying our understanding of glioblastoma tumor biology to diagnosis and treatment
Wolfgang Wick, MD, PhD
The impact of new data on optimizing the standards of care in newly diagnosed glioblastoma
Minesh P. Mehta, MD
Clinical scenario discussion: Treatment considerations for a patient with newly diagnosed glioblastoma
Moderator: Michael Prados, MD
Panelists: Timothy Cloughesy, MD; Minesh P. Mehta, MD; Wolfgang Wick, MD, PhD
Examining novel approaches for the management of recurrent glioblastoma
Timothy Cloughesy, MD
Clinical scenario discussion: Treatment considerations for a patient with recurrent glioblastoma
Moderator: Michael Prados, MD
Panelists: Timothy Cloughesy, MD; Minesh P. Mehta, MD; Wolfgang Wick, MD, PhD
|
LEARNING OBJECTIVES | After successful completion of this educational activity, participants should be able to:
- Discuss the classification, pathophysiology, and current role of biomarkers for glioblastoma.
- Review current standards of care for newly diagnosed and recurrent glioblastoma, including patient selection strategies and optimization of chemotherapy regimens.
- Compare and contrast the safety and efficacy of targeted therapies for treatment of glioblastoma and identify the molecular basis for their use.
- Make informed decisions regarding enrollment in ongoing clinical trials investigating novel therapies in glioblastoma
|
|
|
|
Organizer | This activity is a prIME Oncology activity.
|
SUPPORT | Support for this activity has been provided by an unrestricted grant from Merck.
|
|
